INTRODUCTION

Psychotherapies and the Practice of Psychiatry
T his supplement on the psychotherapies represents a most important and timely undertaking on the part ofthe Canadian Psychiatric Association (CPA). The 1985 CPA position paper on psychotherapy established the place of psychotherapy as a skill of a competent psychiatrist. In May 1996, the CPA approved the terms ofreference for the Psychotherapies Steering Committee, which in part was to lead to a revised position paper and clinical practice guidelines on the psychotherapies. This supplement includes discussion papers on both subjects, reporting on the work of the Psychotherapies Steering Committee and requesting the input ofpsychiatrists who are actively involved in providing care to patients. Basic to both papers is the question ofthe present and future role of psychiatrists in providing care in an environment where the effectiveness ofbiological treatments is both recognized and sought after, the short-term psychotherapies are gaining recognition as being effective in their own right, and long-term dynamic psychotherapy continues to be an important element ofpsychiatric treatment, as it has been for decades throughout the world.
These papers begin to address policy questions that arise among psychiatrists, the popular press, third-party payers, and governments who are interested in providing psychiatric care in a cost-effective manner. Is the goal of treatment to control symptoms or to return individuals to their highest possible level offunctioning, which includes having quality relationships, self-esteem, and, where possible, employment? What is the appropriate place of the psychotherapies and pharmacotherapies in the treatment of individuals with mental illnesses running the full spectrum, and who should provide the treatment deemed necessary? Who should prescribe the treatment, and who should deliver same? Is split treatment, when delivered in an uncoordinated fashion by multiple professionals (commonly seen in the managed-care environment of the United States), cost-effective, and is this the path Canadian psychiatry should follow? Is psychotherapy an essential part of psychopharmacology? Is integrated treatment the way of the future? Should psychiatrists be trained to deliver the short-term psychotherapies, or should they leave these treatments to other professionals? Who are the seriously mentally ill, and do they require and deserve the full complement of psychiatric treatments? Are the goals and objectives of postgraduate education such that the psychiatrist of the future will be trained to provide integrated care that spans the range of psychiatric therapy?
There is no longer any question as to the effectiveness ofpsychiatric treatments, and I believe that they are immeasurably enhanced by the biological treatments now available, but only if psychiatrists continue to provide the psychotherapies when indicated. Psychiatrists must speak out against a growing lobby that sees psychiatry as limited to pharmacotherapy and, at best, supplemented by psychotherapy provided by other professionals. This role, recommended in the name of a more cost-effective health care system, overlooks the offset costs that patients and families continue to pay when patients are not returned to their highest possible level ofproductivity.
These discussion papers will serve their intended purpose only if they receive the attention of Canadian psychiatrists. Read the papers carefully. The CPA welcomes your comments to enhance the future development of a position paper and clinical practice guidelines on the psychotherapies. It is hoped that the CPA Annual Meeting in Toronto in September 1999 will provide an opportunity to obtain the views ofall attendees. 
